174 related articles for article (PubMed ID: 28440407)
1. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
[TBL] [Abstract][Full Text] [Related]
2. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
3. [Expression of CYP3A5 mRNA in children with acute leukemia].
Huang Z; Chai YH; Cen JN; He HL; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):549-54. PubMed ID: 19650988
[TBL] [Abstract][Full Text] [Related]
4. [The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines].
Wang T; Chen FY; Han JY; Zhong JH; Teng Y; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):527-9. PubMed ID: 15312409
[TBL] [Abstract][Full Text] [Related]
5. The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.
Sims RP
J Oncol Pharm Pract; 2016 Feb; 22(1):76-81. PubMed ID: 25305360
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.
Kayilioğlu H; Kocak U; Kan Karaer D; Percin EF; Sal E; Tekkesin F; Isik M; Oner N; Belen FB; Yilmaz Keskin E; Okur A; Albayrak M; Kaya Z; Pinarli FG; Yenicesu I; Karadeniz C; Oguz A; Gursel T
J Pediatr Hematol Oncol; 2017 Aug; 39(6):458-462. PubMed ID: 28697165
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis].
Shen LJ; Chen FY; Wang T; Wang HR; Zhong JH; Han JY; Ouyang RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):26-30. PubMed ID: 18315894
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
Blanco JG; Edick MJ; Hancock ML; Winick NJ; Dervieux T; Amylon MD; Bash RO; Behm FG; Camitta BM; Pui CH; Raimondi SC; Relling MV
Pharmacogenetics; 2002 Nov; 12(8):605-11. PubMed ID: 12439220
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia.
Hartman A; van Schaik RH; van der Heiden IP; Broekhuis MJ; Meier M; den Boer ML; Pieters R
Leuk Res; 2010 Feb; 34(2):154-9. PubMed ID: 19467705
[TBL] [Abstract][Full Text] [Related]
11. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.
Sailaja K; Rao DN; Rao DR; Vishnupriya S
Asian Pac J Cancer Prev; 2010; 11(3):781-4. PubMed ID: 21039054
[TBL] [Abstract][Full Text] [Related]
13. Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
Bedewy AM; El-Maghraby SM
Hematology; 2013 Jul; 18(4):211-6. PubMed ID: 23394475
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
15. Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection.
Rekers NV; Flaig TM; Mallat MJK; Spruyt-Gerritse MJ; Zandbergen M; Anholts JDH; Bajema IM; Clahsen-van Groningen MC; Yang J; de Fijter JW; Claas FHJ; Brakemeier S; Lachmann N; Kreutz R; de Heer E; Budde K; Bolbrinker J; Eikmans M
Transplantation; 2017 Sep; 101(9):2017-2025. PubMed ID: 27926596
[TBL] [Abstract][Full Text] [Related]
16. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.
Uesugi M; Kikuchi M; Shinke H; Omura T; Yonezawa A; Matsubara K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
Pharmacogenet Genomics; 2014 Jul; 24(7):356-66. PubMed ID: 24911663
[TBL] [Abstract][Full Text] [Related]
17. The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.
Flores-Pérez C; Castillejos-López MJ; Chávez-Pacheco JL; Dávila-Borja VM; Flores-Pérez J; Zárate-Castañón P; Acosta-Bastidas M; Cruz-Escobar J; Torres-Espíndola LM
J Clin Pharm Ther; 2021 Jun; 46(3):633-639. PubMed ID: 33638195
[TBL] [Abstract][Full Text] [Related]
18. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
19. Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.
Miura M; Satoh S; Inoue K; Kagaya H; Saito M; Inoue T; Habuchi T; Suzuki T
Steroids; 2008 Oct; 73(11):1052-9. PubMed ID: 18502461
[TBL] [Abstract][Full Text] [Related]
20. CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.
Aplenc R; Glatfelter W; Han P; Rappaport E; La M; Cnaan A; Blackwood MA; Lange B; Rebbeck T
Br J Haematol; 2003 Jul; 122(2):240-4. PubMed ID: 12846892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
